Publications en collaboration avec des chercheurs de Hospital Universitario de Jaén (6)

2018

  1. First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study

    European Journal of Cancer, Vol. 101, pp. 263-272

2009

  1. Reconocimiento clínico del carcinoma oral precoz

    RCOE: Revista del Ilustre Consejo General de Colegios de Odontólogos y Estomatólogos de España, Vol. 14, Núm. 2, pp. 219-226

2008

  1. A Phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer

    Clinical Breast Cancer, Vol. 8, Núm. 3, pp. 264-268

2004

  1. Collagenous fibroma (desmoplastic fibroblastoma) of the palate associated with Marfan's syndrome

    Oral Oncology Extra, Vol. 40, Núm. 3, pp. 39-42

2001

  1. Biweekly gemcitabine, doxorubicin, and paclitaxel as first-line treatment in metastatic breast cancer: Final results from a phase II trial

    ONCOLOGY, Vol. 15, Núm. 2 SUPPL. 3, pp. 44-47

2000

  1. Phase II trial of gemcitabine/doxorubicin/paclitaxel administered every other week in patients with metastatic breast cancer.

    Clinical breast cancer, Vol. 1, Núm. 3, pp. 226-232